April 3rd 2024
This alters the course of developer Eisai's regulatory submission plans for lecanemab in the treatment of early Alzheimer disease.
Psychiatry Roundup: March 2016
April 5th 2016Editors' choices of noteworthy psychiatry stories from around the Web: genetics of schizophrenia, Alzheimer disease, the perils of mixing prescription and over-the-counter medications, new guidelines for treating pain with opioids, and other topics.
Read More
Transcranial Magnetic Stimulation in Neuropsychiatry: An Update
February 27th 2015The potential of TMS as a treatment for cognitive disorders, fatigue, pain, and other manifestations of brain disease is discussed, as is the encouraging prospect for neuropsychiatric management of many patients.
Read More